Boér K - Search Results

1

[Pharmaceutical therapy of breast cancer].

Láng I, Kahán Z, Pintér T, Dank M, Boér K, Pajkos G, Faluhelyi Z, Pikó B, Eckhardt S, Horváth Z. Láng I, et al. Among authors: boer k. Magy Onkol. 2010 Sep;54(3):237-54. doi: 10.1556/MOnkol.54.2010.3.5. Magy Onkol. 2010. PMID: 20870601 Free article. Hungarian. No abstract available.

2

[Current trends in pharmacotherapy of breast cancer].

Boér K. Boér K. Orv Hetil. 2002 Apr 7;143(14):725-30. Orv Hetil. 2002. PMID: 11975393 Review. Hungarian.

3

[Hungarian experience with docetaxel combination (TAC) in the adjuvant treatment of breast cancer. Results of BCIRG 001 randomized, multicentric, phase III trial].

Boér K, Láng I, Juhos E, Pintér T, Szántó J. Boér K, et al. Magy Onkol. 2003;47(2):141-8. Epub 2003 Sep 16. Magy Onkol. 2003. PMID: 12975660 Free article. Clinical Trial. Hungarian.

4

Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC).

Boér K, Láng I, Juhos E, Pintér T, Szántó J. Boér K, et al. Pathol Oncol Res. 2003;9(3):166-9. doi: 10.1007/BF03033731. Epub 2003 Oct 7. Pathol Oncol Res. 2003. Retraction in: Pathol Oncol Res. 2003;9(3):165. PMID: 14530809 Free article. Retracted. Clinical Trial.

5

[Systemic pharmacotherapy in breast cancer].

Boér K. Boér K. Orv Hetil. 2004 Jan 25;145(4):187-92. Orv Hetil. 2004. PMID: 14978885 Review. Hungarian. No abstract available.

6

[Effective treatment strategy in elderly breast cancer patients].

Boér K. Boér K. Orv Hetil. 2005 Jan 2;146(1):15-21. Orv Hetil. 2005. PMID: 15715368 Review. Hungarian.

7

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study.

Boér K, Láng I, Llombart-Cussac A, Andreasson I, Vivanco GL, Sanders N, Pover GM, Murray E. Boér K, et al. Invest New Drugs. 2012 Apr;30(2):681-7. doi: 10.1007/s10637-010-9538-8. Epub 2010 Sep 10. Invest New Drugs. 2012. PMID: 20830502 Clinical Trial.

8

Adjuvant trastuzumab in HER2-positive breast cancer.

Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.

9

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.

Mackey JR, Martin M, Pienkowski T, Rolski J, Guastalla JP, Sami A, Glaspy J, Juhos E, Wardley A, Fornander T, Hainsworth J, Coleman R, Modiano MR, Vinholes J, Pinter T, Rodríguez-Lescure A, Colwell B, Whitlock P, Provencher L, Laing K, Walde D, Price C, Hugh JC, Childs BH, Bassi K, Lindsay MA, Wilson V, Rupin M, Houé V, Vogel C; TRIO/BCIRG 001 investigators. Mackey JR, et al. Lancet Oncol. 2013 Jan;14(1):72-80. doi: 10.1016/S1470-2045(12)70525-9. Epub 2012 Dec 12. Lancet Oncol. 2013. PMID: 23246022 Clinical Trial.

10

A comparative analysis on the efficacy and safety of intaxel® and taxol® in advanced metastatic breast cancer.

Lang I, Rubovszky G, Horvath Z, Ganofszky E, Szabo E, Dank M, Boer K, Hitre E. Lang I, et al. Among authors: boer k. J Clin Diagn Res. 2013 Jun;7(6):1120-4. doi: 10.7860/JCDR/2013/4742.3027. Epub 2013 Jun 1. J Clin Diagn Res. 2013. PMID: 23905117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

488 results

Search Page

Filters